A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis
Background: The treatment landscape for myasthenia gravis (MG) has evolved with the introduction of novel therapies. An international consensus on patient selection criteria and optimal time to initiate these therapies could improve clinical outcomes and reduce delays for likely beneficiaries. Objec...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2026-04-01
|
| Col·lecció: | Therapeutic Advances in Neurological Disorders |
| Accés en línia: | https://doi.org/10.1177/17562864261429176 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|